Investment
Features
FeesSafety
Academy
More
Pluang+

Compare FuelCell Energy Inc (FCEL) vs Johnson & Johnson (JNJ) Price & Performance

FuelCell Energy IncTrade
Johnson & JohnsonTrade

Price performance (Past 24H)

Key statistics

FuelCell Energy Inc vs Johnson & Johnson — how do they compare? FuelCell Energy Inc trades at $19.42 (market cap $1.59B), while Johnson & Johnson trades at $259.8 (market cap $630.94B). The key difference: Johnson & Johnson is far larger — about 396.8× FuelCell Energy Inc's market cap, and Johnson & Johnson pays a 2.05% dividend while FuelCell Energy Inc pays none. Which is the better fit depends on your goals.

FCELJNJ
Market Cap
$1.59B$630.94B
Sector
IndustrialsHealth
52-Week High
$36.01$267.24
52-Week Low
$3.92$172.78
Enterprise Value
$1.43B$659.21B
Volume
6,156,228
Dividend Yield
2.05%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

FuelCell Energy Inc

FCEL trades at $20.43, up 0.54% today, near the analyst consensus target of $20.75. The stock shows a bearish technical signal with negative moving averages, while fundamentals reveal persistent losses: revenue grew to $158.16M in 2025 but net income margin was -132.41%. Recent news highlights partnerships with Siemens and AI data center demand as growth catalysts, though cash flow from operations remains negative at -$125.29M.

FCEL presents high-risk growth potential driven by alternative energy tailwinds and strategic alliances, but investment is speculative due to unprofitability, cash burn, and competitive pressures. Analysts are split evenly between Buy and Hold ratings, reflecting cautious optimism amid financial challenges. The stock's outlook hinges on execution toward profitability and scaling commercial projects.

Johnson & Johnson

Johnson & Johnson (JNJ) trades at $259.24, up 0.88% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $282.33. Recent earnings beat expectations in Q1 and Q2 2026, with Q3 results pending. The company maintains strong profitability, including a 67.91% gross margin and 21.48% net income margin, supported by consistent dividend payments, including a recent $1.34 per share payout.

JNJ offers stability with a 64-year dividend growth streak and robust fundamentals, but risks include rising debt-to-asset ratios (24.06% in 2025) and sector volatility. Upside potential hinges on execution of growth initiatives and healthcare market dynamics, with analysts favoring a buy rating (52.5% consensus).

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About FuelCell Energy Inc

FuelCell Energy Inc is a fuel-cell power company. FuelCell designs manufactures, sells, installs, operates, and services fuel cell products, which efficiently convert chemical energy in fuels into electricity through a series of chemical reactions. It serves various industries such as Industrial, Wastewater treatment, Commercial and Hospitality, Data centers and Communications, Education and Healthcare, and others. Geographically, the company generates a majority of its revenue from the United States followed by South Korea.

Read more on FCEL

About Johnson & Johnson

Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.

Read more on JNJ